middle.news
Zelira Therapeutics Secures US$33M Fundraising to Propel HOPE® 1 FDA Trials
11:00am on Thursday 30th of July, 2026 AEST
•
Healthcare
Read Story
Zelira Therapeutics Secures US$33M Fundraising to Propel HOPE® 1 FDA Trials
11:00am on Thursday 30th of July, 2026 AEST
Key Points
US$33 million raised for HOPE® 1 SPV
Zelira retains 39.7% equity in SPV post-fundraising
Fundraising supports FDA IND submission and Phase 1 trial
Operational cash outflow of $154k in Q4 FY2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Zelira Therapeutics (ASX:ZLD)
OPEN ARTICLE